{
  "api": "assay-systems/v1",
  "key_tier": "none",
  "retrieved": "2026-10-16T15:54:34Z",
  "source": "Assay Systems register, https://assay-systems.com/register/",
  "access_notice": "On 15 November 2026, automated access to assay-systems.com closes. After that date, access is available only under a paid annual subscription contract. Contact: contact@assay-systems.com",
  "data": {
    "id": "ASY-CA-1QN9Z7V0SD",
    "type": "grant",
    "country": "ca",
    "name": "Kisoji Biotechnologie Inc.: federal grants and contributions",
    "url": "https://assay-systems.com/register/ca/grants/r/kisoji-biotechnologie-inc/",
    "summary": "6 federal grant and contribution agreements worth $2.1M with Kisoji Biotechnologie Inc., 2017–2024.",
    "figures": [
      {
        "label": "agreements",
        "value": 6,
        "unit": "count"
      },
      {
        "label": "value",
        "value": 2100000,
        "unit": "money",
        "currency": "CAD",
        "approximate": true,
        "display": "$2.1M"
      },
      {
        "label": "departments",
        "value": 1,
        "unit": "count"
      },
      {
        "label": "programs",
        "value": 2,
        "unit": "count"
      }
    ],
    "text": [
      "Through the development and application of cutting-edge machine learning algorithms, the firm seek to build an end-to-end AI-enabled platform, KisoSeek, that will use machine learning to search and identify therapeutic cancer antibodies.",
      "The firm will use machine learning to predict the 3D structure of antibodies more accurately and rapidly than existing technologies. A tool will be developed to provide antibody structures. The enhanced AI-enabled platform will be used to search and identify therapeutic antibodies.",
      "Cancer remains a very important disease in North America and the world. Antibodies have emerged as an effective treatment for cancer. KisoJi is developing antibodies for treatment of newly diagnosed cancers and for previously treated cancers.",
      "The funding provided by the IAP program is intended to assist innovative small and medium-sized enterprises in the start-up phase that cannot access existing commercial support related to COVID-19.",
      "As part of Multinational Corporate Collaboration Program, the project “KisoJi Biotechnology Inc. Research Collaboration” will focus on solidifying a partnership with a large multinational corporation and further developing the scope of a larger R&D collaboration project."
    ],
    "records": [
      {
        "name": "grants and contributions register",
        "url": "https://assay-systems.com/register/ca/grants/"
      },
      {
        "name": "Ville-Marie–Le Sud-Ouest–Île-des-Soeurs",
        "url": "https://assay-systems.com/register/ca/grants/riding/24077-ville-marie-le-sud-ouest-le-des-soeurs/"
      },
      {
        "name": "National Research Council Canada",
        "url": "https://assay-systems.com/register/ca/grants/department/national-research-council-canada/"
      },
      {
        "name": "Vimy",
        "url": "https://assay-systems.com/register/ca/grants/riding/24078-vimy/"
      }
    ],
    "assay_record": "ASY-CA-1QN9Z7V0SD",
    "cite_as": "Assay Systems, \"Kisoji Biotechnologie Inc.: federal grants and contributions\", https://assay-systems.com/register/ca/grants/r/kisoji-biotechnologie-inc/"
  }
}